ArticleScientific reports2021

HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation.

Tahiyat Alothaim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.